FertiSCI: Fertility of Spinal Cord Injured Men

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Completed
CT.gov ID
NCT02144558
Collaborator
Agence de La Biomédecine (Other)
35
1
1
47.4
0.7

Study Details

Study Description

Brief Summary

Spinal cord injured (SCI) men, para or tetraplegic, most often have an infertility, caused among others by a deficiency of sperm quality particularly motility and vitality. Several mechanisms have been proposed: low frequency of ejaculation, recurrent urinary tract and seminal infections, presence of an inflammatory syndrome (IS) and an oxidative stress (OS). However, no French study of sperm quality has been conducted in this population that could identify aggravating factors of sperm quality and a way to prevent them.

Hypothesis: Sperm parameters decrease rapidly following spinal cord injury and next stabilise. However, unidentified yet risk factors could influence long-term evolution of sperm parameters.

The objective is to study the evolution of sperm parameters during 18 months taking into account bladder management, recurrent urinary tract and bladder infections, IS and OS. The evaluation of these parameters and their consequences will be indicative to determine one or more risk factors of sperm degradation and determine a strategy for long term support to avoid the use of ART either by sperm cryopreservation and/or by preventing risk factors

Condition or Disease Intervention/Treatment Phase
  • Other: penile vibratory stimulation (PVS) or masturbation
N/A

Detailed Description

SCI men are mostly young adults who have not completed their parental project. Infertility has many causes: erectile dysfunction, anejaculation (85% of SCI ) and altered sperm parameters. Penile vibratory stimulation allows 75 % of the sperm collection. If sperm quality is sufficient, intravaginal insemination of their partner at home is possible. The use of AMP remains common, which is damaging to men non sterile priori. In SCI, sperm concentration remains satisfactory but mobility and vitality are impaired. The installation of this irreversible degradation likely occurs very quickly after the trauma. The possible deterioration of sperm parameters with time is not known. The following pathophysiological mechanisms have been proposed: i) increased scrotal temperature, ii) decreased ejaculatory frequency, iii) recurrent urinary tract and seminal infections, iv ) inflammation and oxidative stress in the semen. Patients, and even rehabilitation doctors often submit an application for preventive sperm conservation but in the absence of prospective longitudinal data on the evolution of sperm quality of SCI men over the time and identified risk factors of degradation, the indication and timing of preventive cryopreservation remain to be defined.

Hypothesis: The sperm parameters, mobility and vitality, in SCI patients with or without penile vibratory stimulation (PVS), decrease in the immediate aftermath of trauma and next stabilize out the occurrence of intercurrent medical events or symptomatic urogenital infections. However, unidentified yet risk factors could influence long-term evolution of these sperm parameters.

Main objective: Monitoring the evolution of sperm parameters for 18 months: concentration, mobility, vitality, sperm morphology, inflammatory syndrome and oxidative stress on 4 ejaculates collected by masturbation or SVP at 6-month intervals.

Secondary objectives: In case of impaired sperm quality, identify risk factors for this change.

SCI men will have 4 medical visits associated to sperm retrieval spaced to 6 months during 18 months. At each visit medical and reproductive informations will be collected.

Knowledge of the evolution of sperm parameters and risk factors of its degradation over time must answer with the criteria of "evidence based medicine" the request of sperm cryopreservation frequently expressed by SCI patients. This study should lead to the optimization of the management of infertility in patients with spinal cord injuries and giving directions for research aiming to prevent the degradation of sperm parameters. Finally, this study should provide the rationale for future research on clinical risk factors and / or biological degradation of sperm and biological markers of risk of degradation.

Study Design

Study Type:
Interventional
Actual Enrollment :
35 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Evolution of Sperm Parameters and Study of Risk Factors of Impairment of Sperm Quality in Spinal Cord Injuries. Longitudinal Prospective Study.
Actual Study Start Date :
Apr 24, 2014
Actual Primary Completion Date :
Apr 5, 2018
Actual Study Completion Date :
Apr 5, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Spinal cord injured (SCI) men, para or tetraplegic

SCI men will have 4 medical visits associated to sperm retrieval (penile vibratory stimulation (PVS) or masturbation)

Other: penile vibratory stimulation (PVS) or masturbation
penile vibratory stimulation (PVS) or masturbation

Outcome Measures

Primary Outcome Measures

  1. Sperm viability: percent of live spermatozoa among 100 counted spermatozoa. [18 month]

    Sperm viability is a stable criteria of evaluation and it has a good repeatability in our lab. Sperm viability is measured on fresh sperm 30 minutes after ejaculation using eosine nigrosine coloration. This measure is repeated on each of the four ejaculates obtained at 6 months apart.

Secondary Outcome Measures

  1. spermogram [18 months]

    Sperm concentration, mobility and morphology

  2. elastase [6 month]

    Measure of inflammation

  3. DNA fragmentation [18 months]

    Sperm DNA integrity, measures oxidative stress

  4. 8 Hydroxydesoxyguanosine (8OHdG) [18 months]

    Oxydative stress

  5. Seminal biochemistry [18 months]

    Secretion of seminal tract

  6. Urinary and seminal infections [18 months]

    Bacteriological analysis of sperm and urine

  7. Mode of urinary catheter [18 months]

  8. Spinal cord injury type [0 months]

    Type and level of the lesion

  9. Concomitant treatments [18 months]

  10. Patient age and time to spinal cord injury [18 months]

  11. Sperm viability: percent of live spermatozoa among 100 counted spermatozoa. [6 months]

    Sperm viability is a stable criteria of evaluation and it has a good repeatability in our lab. Sperm viability is measured on fresh sperm 30 minutes after ejaculation using eosine nigrosine coloration. This measure is repeated on each of the four ejaculates obtained at 6 months apart.

  12. Sperm viability: percent of live spermatozoa among 100 counted spermatozoa. [12 months]

    Sperm viability is a stable criteria of evaluation and it has a good repeatability in our lab. Sperm viability is measured on fresh sperm 30 minutes after ejaculation using eosine nigrosine coloration. This measure is repeated on each of the four ejaculates obtained at 6 months apart.

  13. Sperm viability: percent of live spermatozoa among 100 counted spermatozoa. [0 months]

    Sperm viability is a stable criteria of evaluation and it has a good repeatability in our lab. Sperm viability is measured on fresh sperm 30 minutes after ejaculation using eosine nigrosine coloration. This measure is repeated on each of the four ejaculates obtained at 6 months apart.

  14. elastase [0 month]

    Measure of inflammation

  15. elastase [12 month]

    Measure of inflammation

  16. elastase [18 month]

    Measure of inflammation

  17. spermogram [0 months]

    Sperm concentration, mobility and morphology

  18. spermogram [6 months]

    Sperm concentration, mobility and morphology

  19. spermogram [12 months]

    Sperm concentration, mobility and morphology

  20. DNA fragmentation [0 month]

    Sperm DNA integrity, measures oxidative stress

  21. DNA fragmentation [6 months]

    Sperm DNA integrity, measures oxidative stress

  22. DNA fragmentation [12 months]

    Sperm DNA integrity, measures oxidative stress

  23. 8 Hydroxydesoxyguanosine (8OHdG) [0 months]

    Oxydative stress

  24. 8 Hydroxydesoxyguanosine (8OHdG) [6 months]

    Oxydative stress

  25. Seminal biochemistry [0 months]

    Secretion of seminal tract

  26. Seminal biochemistry [6 months]

    Secretion of seminal tract

  27. Seminal biochemistry [12 months]

    Secretion of seminal tract

  28. Urinary and seminal infections [0 months]

    Bacteriological analysis of sperm and urine

  29. Urinary and seminal infections [6 months]

    Bacteriological analysis of sperm and urine

  30. Urinary and seminal infections [12 months]

    Bacteriological analysis of sperm and urine

  31. Mode of urinary catheter [0 months]

  32. Mode of urinary catheter [6 months]

  33. Mode of urinary catheter [12 months]

  34. Concomitant treatments [0 month]

  35. Concomitant treatments [6 months]

  36. Concomitant treatments [12 months]

  37. Patient age and time to spinal cord injury [0 month]

  38. Patient age and time to spinal cord injury [6 months]

  39. Patient age and time to spinal cord injury [12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Spinal cord injured men aged between 18 and 60 years

  • Strict antegrade ejaculation obtained by masturbation or penil vibratory stimulation

  • Signature of an informed and written consent to participate to the study.

Exclusion Criteria:
  • Total or partial retrograde ejaculation

  • Major patients protected

  • Men no affiliated with a french social security regime.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Department of Biology of Reproduction Paris France 75014

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris
  • Agence de La Biomédecine

Investigators

  • Principal Investigator: Céline Chalas, PhD, Cochin Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT02144558
Other Study ID Numbers:
  • P130703
First Posted:
May 22, 2014
Last Update Posted:
Apr 19, 2021
Last Verified:
Apr 1, 2021
Keywords provided by Assistance Publique - Hôpitaux de Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 19, 2021